Loading clinical trials...
Loading clinical trials...
Early oral intake after Pancreaticoduodenectomy is recommended strongly according to the ERAS guideline, which was based on studies in patients with gastrointestinal cancer, mainly colorectal and gast...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Xuzhou Medical University
Collaborators
NCT07514637 · Patients Who Undergo Pancreaticoduodenectomy
NCT07132541 · Pancreaticoduodenectomy, Postoperative Pancreatic Fistula, and more
NCT07081360 · Pancreas Cancer, Periampullary Cancer, and more
NCT06630910 · Periampullary Carcinoma Resectable, Pancreatic Tumors, and more
NCT07038161 · Pancreaticoduodenectomy, Distal Pancreatectomy, and more
Suqian Hospital
Suqian, Jiangsu
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions